ArticleHeliyon2024
A disproportionality analysis of sunitinib in the FDA adverse event reporting system (FAERS).
Wenbin Zou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleHeliyon2024
Wenbin Zou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.